Comment on "Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome"

Science

Volumn 328, Issue 5980, 2010, Pages

  Lloyd, Andrew ^a   White, Peter ^b   Wessely, Simon ^c   Sharpe, Michael ^d   Buchwald, Dedra ^e  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RIBONUCLEASE L;

BLOOD CELL; CHRONIC FATIGUE SYNDROME; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; HUMAN; NONHUMAN; NOTE; PRIORITY JOURNAL; RETROVIRUS; RISK ASSESSMENT; VALIDATION PROCESS; VIRUS DETECTION; XENOTROPIC MURINE LEUKEMIA VIRUS RELATED VIRUS; CASE CONTROL STUDY; EPIDEMIOLOGY; ISOLATION AND PURIFICATION; REPRODUCIBILITY; RETROVIRUS INFECTION; VIROLOGY; VIRUS INFECTION;

BLOOD CELLS; CASE-CONTROL STUDIES; EPIDEMIOLOGIC RESEARCH DESIGN; FATIGUE SYNDROME, CHRONIC; GAMMARETROVIRUS; HUMANS; REPRODUCIBILITY OF RESULTS; RETROVIRIDAE INFECTIONS; TUMOR VIRUS INFECTIONS;

EID: 77952411103     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1183706     Document Type: Note

References (13)

1. V. C. Lombardi et al., Science 326, 585 (2009).
2. E. DeFreitas et al., Proc. Natl. Acad. Sci. U.S.A. 88, 2922 (1991).
3. J. W. Gow et al., J. Clin. Pathol. 45, 1058 (1992).
4. M. Honda et al., Microbiol. Immunol. 37, 779 (1993).
5. A. S. Khan et al., Ann. Intern. Med. 118, 241 (1993).
6. W. Heneine et al., Clin. Infect. Dis. 18 (suppl. 1), S121 (1994).
7. M. Lyall, M. Peakman, S. Wessely, J. Psychosom. Res. 55, 79 (2003).
8. R. Schlaberg, D. J. Choe, K. R. Brown, H. M. Thaker, I. R. Singh, Proc. Natl Acad. Sci. U.S.A. 106, 16351 (2009).
9. O. Hohn et al., Retrovirology 6, 92 (2009).
10. O. Erlwein et al., PLoS ONE 5, e8519 (2010).
11. H. C. Groom et al., Retrovirology 7, 10 (2010).
12. F. J. M. van Kuppeveld et al., BMJ 340, c1018 (2010).
13. M.S. has been paid by insurers for independent advice on medical claims that might include CFS. He has also been paid by lawyers for independent advice on litigation that might include CFS.